Wikisage, the free encyclopedia of the second generation, is digital heritage
Zonisamide: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
zonisamide | zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug. | ||
1,2-benzisoxazole-3-methanesulfonamide | |||
It inhibitory action against carbonic anhydrase could be related with perception of taste, and the novo lipogenesis. | |||
<ref>[http://ac.els-cdn.com/S071686401270295X/1-s2.0-S071686401270295X-main.pdf?_tid=015b25bc-89ef-11e7-8ccc-00000aacb35d&acdnat=1503704707_e514043afaffa54860aa6f4fa522df67 Tratamiento farmacológico de la obesidad Pharmacological obesity treatment]</ref> | |||
==LINK== | |||
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis | [https://www.ncbi.nlm.nih.gov/books/NBK1520/ MERFF] : Myoclonic Epilepsy Associated with Ragged Red Fibers | ||
[http://www.sciencedirect.com/science/article/pii/S0168010217301785?via%3Dihub Zonisamide inhibits monoaminooxidase and enhances motor perfomance and social activity] | |||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451432/ Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis] | |||
<references/> | |||
{{wikidata|Q219957}} | |||
Latest revision as of 00:04, 26 August 2017
zonisamide is an 1,2-benzisoxazole-3-methanesulfonamide, that was initally used as anticonvulsant drug and latter as Parkinson-drug.
It inhibitory action against carbonic anhydrase could be related with perception of taste, and the novo lipogenesis. [1]
LINK
MERFF : Myoclonic Epilepsy Associated with Ragged Red Fibers
Zonisamide inhibits monoaminooxidase and enhances motor perfomance and social activity
